Literature DB >> 8452232

Maximal expression of recombinant cDNAs in COS cells for use in expression cloning.

F W Kluxen1, H Lübbert.   

Abstract

In the process of establishing an expression cloning system for cell surface receptors we examined parameters which influence the expression of foreign genes in COS cells. The bacterial beta-galactosidase gene was chosen as a reporter gene, since it permits the determination of (i) the fraction of cells transfected as well as (ii) the total activity of the synthesized enzyme in parallel experiments. This renders it possible to calculate the enzyme activity per individual cell. In transfected COS cells, the plasmid pXMgal directed a 20- and 10-fold higher beta-galactosidase activity than pCH110 and pCDLgal, respectively. DEAE-dextran-mediated DNA uptake and protoplast fusion were found to result in higher expression rates than lipofection and electroporation. A coincubation of the cells with chloroquine during the DEAE-dextran transfection protocol caused, as reported, an increase of beta-galactosidase positive cells but considerably reduced the total beta-galactosidase activity. However, a 10% DMSO shock at the end of the transfection procedure simultaneously increased the number of transfected cells and the total beta-galactosidase activity, thus maintaining the high expression per single cell. Using these optimized conditions, COS-1 cells expressed higher amounts of recombinant protein than COS-7 cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8452232     DOI: 10.1006/abio.1993.1060

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  11 in total

1.  Initiator-elongator discrimination in vertebrate tRNAs for protein synthesis.

Authors:  H J Drabkin; M Estrella; U L Rajbhandary
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

2.  The product of the murine homolog of the Drosophila extra sex combs gene displays transcriptional repressor activity.

Authors:  O N Denisenko; K Bomsztyk
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

3.  Initiation of protein synthesis in mammalian cells with codons other than AUG and amino acids other than methionine.

Authors:  H J Drabkin; U L RajBhandary
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

4.  Novel partners of SPAG11B isoform D in the human male reproductive tract.

Authors:  Yashwanth Radhakrishnan; Katherine G Hamil; Jiann-An Tan; Gail Grossman; Peter Petrusz; Susan H Hall; Frank S French
Journal:  Biol Reprod       Date:  2009-06-17       Impact factor: 4.285

5.  Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor.

Authors:  R Calligaris; S Bottardi; S Cogoi; I Apezteguia; C Santoro
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

6.  Point mutations in the WD40 domain of Eed block its interaction with Ezh2.

Authors:  O Denisenko; M Shnyreva; H Suzuki; K Bomsztyk
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

7.  Tetracycline-regulated suppression of amber codons in mammalian cells.

Authors:  H J Park; U L RajBhandary
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

8.  The integrin cytoplasmic domain-associated protein ICAP-1 binds and regulates Rho family GTPases during cell spreading.

Authors:  Simona Degani; Fiorella Balzac; Mara Brancaccio; Simona Guazzone; Saverio Francesco Retta; Lorenzo Silengo; Alessandra Eva; Guido Tarone
Journal:  J Cell Biol       Date:  2002-01-21       Impact factor: 10.539

9.  Distinct effects of endosomal escape and inhibition of endosomal trafficking on gene delivery via electrotransfection.

Authors:  Lisa D Cervia; Chun-Chi Chang; Liangli Wang; Fan Yuan
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

10.  Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules.

Authors:  J Thibodeau; N Labrecque; F Denis; B T Huber; R P Sékaly
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.